Literature DB >> 11280791

Clinicopathological significance of core 2 beta1,6-N-acetylglucosaminyltransferase messenger RNA expressed in the pulmonary adenocarcinoma determined by in situ hybridization.

E Machida1, J Nakayama, J Amano, M Fukuda.   

Abstract

Cell surface carbohydrates of epithelial cells play important roles in tumor progression. Previously, we have shown that expression of core 2 branched O-glycans in colorectal cancer is closely correlated with the vessel invasion and depth of invasion (K. Shimodaira et al., Cancer Res., 57: 5201-5206, 1997). To test whether this is also the case in human lung cancer, we have examined the expression pattern of core 2 beta1,6-N-acetylglucosaminyltransferase (C2GnT) mRNA responsible for the biosynthesis of core 2 branched O-glycans in 41 cases of lung cancer. Using in situ hybridization, C2GnT mRNA was detected in 73.2% of the lung cancer cells, irrespective of the histopathological type; whereas in normal lung tissues, its expression was restricted to the basal cells of bronchial mucosa. These results indicate that the expression level of C2GnT mRNA was significantly enhanced in association with malignant transformation. Statistical analysis between the C2GnT mRNA expressed in pulmonary adenocarcinoma and clinicopathological variables revealed that the expression of C2GnT was correlated with vessel invasion and lymph node metastasis with significant difference (P < 0.05), but expression of sialyl Le(x), which is frequently expressed in the adenocarcinoma, was not significantly correlated with lymph node metastasis. These results indicate that C2GnT mRNA detected by in situ hybridization reflects the malignant potentials of pulmonary adenocarcinoma, because lymph node metastasis is the most affecting factor to the patients' prognosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11280791

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  Two opposing roles of O-glycans in tumor metastasis.

Authors:  Shigeru Tsuboi; Shingo Hatakeyama; Chikara Ohyama; Minoru Fukuda
Journal:  Trends Mol Med       Date:  2012-03-16       Impact factor: 11.951

2.  MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.

Authors:  Yuichiro Suzuki; Mihoko Sutoh; Shingo Hatakeyama; Kazuyuki Mori; Hayato Yamamoto; Takuya Koie; Hisao Saitoh; Kanemitsu Yamaya; Tomihisa Funyu; Tomonori Habuchi; Yoichi Arai; Minoru Fukuda; Chikara Ohyama; Shigeru Tsuboi
Journal:  Int J Oncol       Date:  2012-03-23       Impact factor: 5.650

3.  Mucin O-glycan branching enzymes: structure, function, and gene regulation.

Authors:  Pi-Wan Cheng; Prakash Radhakrishnan
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

4.  A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans.

Authors:  Shigeru Tsuboi; Mihoko Sutoh; Shingo Hatakeyama; Nobuyoshi Hiraoka; Tomonori Habuchi; Yohei Horikawa; Yasuhiro Hashimoto; Takahiro Yoneyama; Kazuyuki Mori; Takuya Koie; Toshiya Nakamura; Hisao Saitoh; Kanemitsu Yamaya; Tomihisa Funyu; Minoru Fukuda; Chikara Ohyama
Journal:  EMBO J       Date:  2011-06-28       Impact factor: 11.598

5.  Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.

Authors:  Seung Ho Lee; Shin-Yi Yu; Jun Nakayama; Kai-Hooi Khoo; Erica L Stone; Michiko N Fukuda; Jamey D Marth; Minoru Fukuda
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

6.  Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor.

Authors:  Shingo Hatakeyama; Atsushi Kyan; Hayato Yamamoto; Akiko Okamoto; Naoki Sugiyama; Yuichiro Suzuki; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Shigeyuki Yamada; Hideo Saito; Yoichi Arai; Minoru Fukuda; Chikara Ohyama
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

7.  Glycosylation potential of human prostate cancer cell lines.

Authors:  Yin Gao; Vishwanath B Chachadi; Pi-Wan Cheng; Inka Brockhausen
Journal:  Glycoconj J       Date:  2012-07-28       Impact factor: 2.916

Review 8.  Glycosylation in bladder cancer.

Authors:  Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

9.  Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex.

Authors:  Seung Ho Lee; Shingo Hatakeyama; Shin-Yi Yu; Xingfeng Bao; Chikara Ohyama; Kai-Hooi Khoo; Michiko N Fukuda; Minoru Fukuda
Journal:  J Biol Chem       Date:  2009-04-24       Impact factor: 5.157

10.  Control of core 2 beta1,6 N-acetylglucosaminyltransferase-I transcription by Sp1 in lymphocytes and epithelial cells.

Authors:  V Rebecca Falkenberg; Nevis Fregien
Journal:  Glycoconj J       Date:  2007-05-26       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.